US$ 21.83
kb glutathione users is critical for NK cell-mediated immunity: Cell Reports Frontiers | Diabetic testicular dysfunction
Description
Competing interests The authors declare that there are no competing of interest

Recent findings and current status of augmentation strategies

Ask your query below.

Meets GMP quality standards

Carr A, Swanson C, Penny R, Cooper DA

Trial in progress: A phase 1, first-in-human, open-label, multicenter, dose-escalation and dose-expansion study of ASP3082 in patients with previously treated advanced solid tumors and KRAS G12D mutations
